Skip to content

Atabak Mokari, Chief Financial Officer at Corcept Therapeutics, sold CORT on Jun 15, 2026

Data as of Oct 16

▼ SELL$897K11,081 shares at $80.94Atabak Mokari Chief Financial OfficerCORT Corcept Therapeutics Inc
Watch CORT
Traded
Jun 15, 2026
Disclosed
Jun 17, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Atabak Mokari, Chief Financial Officer at Corcept Therapeutics, sold CORT on Jun 15, 2026TRADEDDISCLOSED
CORTSimilar stocks (XLV — its sector index fund), rebased to CORT's price on the disclosure day
CORT since disclosure
+34.8%
after the sale
Similar stocks (XLV) since disclosure
+17.3%
XLV — its sector index fund

Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLAtabak Mokari Chief Financial OfficerCORT Corcept Therapeutics Inc$165disclosed Jun 17 · filed 2 days after the trade
  2. ▼ SELLAtabak Mokari Chief Financial OfficerCORT Corcept Therapeutics Inc$755Kdisclosed Jun 17 · filed 2 days after the trade
  3. ▼ SELLAtabak Mokari Chief Financial OfficerCORT Corcept Therapeutics Inc$1.6Mdisclosed Jun 17 · filed 2 days after the trade

See every trade on CORT →